Curcumin inhibits AP-2γ-induced apoptosis in the human malignant testicular germ cells in vitro

Acta Pharmacol Sin. 2013 Sep;34(9):1192-200. doi: 10.1038/aps.2013.38. Epub 2013 May 20.

Abstract

Aim: To investigate the effects of curcumin on proliferation and apoptosis in testicular cancer cells in vitro and to investigate its molecular mechanisms of action.

Methods: NTera-2 human malignant testicular germ cell line and F9 mouse teratocarcinoma stem cell line were used. The anti-proliferative effect was examined using MTT and colony formation assays. Hoechst 33258 staining, TUNEL and Annexin V-FITC/PI staining assays were used to analyze cell apoptosis. Protein expression was examined with Western blot analysis and immunocytochemical staining.

Results: Curcumin (5, 10 and 15 μmol/L) inhibited the viability of NTera-2 cells in dose- and time-dependent manners. Curcumin significantly inhibited the colony formation in both NTera-2 and F9 cells. Curcumin dose-dependently induced apoptosis of NTera-2 cells by reducing FasL expression and Bcl-2-to-Bax ratio, and activating caspase-9, -8 and -3. Furthermore, curcumin dose-dependently reduced the expression of AP transcription factor AP-2γ in NTera-2 cells, whereas the pretreatment with the proteasome inhibitor MG132 blocked both the curcumin-induced reduction of AP-2γ and antiproliferative effect. Curcumin inhibited ErbB2 expression, and decreased the phosphorylation of Akt and ERK in NTera-2 cells.

Conclusion: Curcumin induces apoptosis and inhibits proliferation in NTera-2 cells via the inhibition of AP-2γ-mediated downstream cell survival signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Cell Proliferation / drug effects*
  • Curcumin / pharmacology*
  • Curcumin / therapeutic use
  • Humans
  • Mice
  • Neoplasms, Germ Cell and Embryonal* / drug therapy
  • Neoplasms, Germ Cell and Embryonal* / pathology
  • Testicular Neoplasms* / drug therapy
  • Testicular Neoplasms* / pathology
  • Transcription Factor AP-2 / antagonists & inhibitors*
  • Transcription Factor AP-2 / pharmacology*

Substances

  • Antineoplastic Agents
  • TFAP2C protein, human
  • Transcription Factor AP-2
  • Curcumin

Supplementary concepts

  • Testicular Germ Cell Tumor